0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Invokana - API Insight,2019
Published Date: March 2019
|
Report Code: DELV-Drug-215
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Invokana API Insight 2019

Invokana - API Insight,2019

Code: DELV-Drug-215
Report
March 2019
30 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's, “Invokana - API Insight, 2019” report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Invokana . The report also highlights the patent details of Invokana .

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report
• A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
• Patent information around Invokana in United States (US) and Europe (EU) has been highlighted
• API manufacturers for Invokana in United States, Europe, China and India
• The report contains historical and forecasted sales for Invokana till 2021
• Enlists the market competition and emerging therapies in the space where Invokana operates

Reasons to Buy
• Evaluate the marketing status of Invokana to exploit opportunities for generic Invokana development opportunities
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Invokana
• API intelligence over Invokana and gaining primary intelligence over Active Ingredient manufacturers by country
• Make more informed business decisions from insightful and in-depth analysis of the Invokana 's performance

1. Invokana Overview
2. Invokana Global Sales Assessment
• Invokana Historical Global Sales
• Invokana Forecasted Global Sales
3. Product Description
• Mechanism of Action
• Pharmacodynamic Properties
• Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
Appendix
Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Invokana Historical Global Sales till 2018 (in million USD)
Table 2: Invokana Forecasted Global Sales from 2019-2021 (in million USD)
Table 3: Invokana General Description
Table 4: Product Details by country
Table 5: Patent Information
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region

List of Figures

Figure 1: Invokana Historical Global Sales till 2018 (in million USD)
Figure 2: Invokana Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: Invokana Patent Details
Figure 4: API Manufacturers by Country
Figure 5: API Manufacturers by Region

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$500
This license allows only one user to access the PDF.

Electronic (PDF)
$1000
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$1500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Type 1 Diabetes Treatment Market Size Status and Forecast 2021 2027
Global Type-1 Diabetes Treatment Market Size, Status and Forecast 2021-2027

Failure to produce insulin is the cause of this type of diabetes.Market Analysis and Insights Global Type1 Diabetes Treatment MarketThe global Type1 Diabetes Treatment market size is projected to reach US 7034.4 million by 2027 from US 5020 million in 2020 at a CAGR of 4.5 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Type1 Diabetes Treatment market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-18I2851
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Self Blood Glucose Monitoring Market Size Status and Forecast 2021 2027
Global Self Blood Glucose Monitoring Market Size, Status and Forecast 2021-2027

Self Blood Glucose Monitoring is an approach whereby people withdiabetesmeasure theirblood sugarglycemia themselves using a glycemic reader.Market Analysis and Insights Global Self Blood Glucose Monitoring MarketThe global Self Blood Glucose Monitoring market size is projected to reach US 18050 million by 2027 from US 11100 million in 2020 at a CAGR of 6.7 during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Self Blood Glucose Monitoring market to help players in achieving a strong market position.

120 Pages
Type: Report
Code: QYRE-Auto-21E1004
Sat Jul 17 00:00:00 UTC 2021

Add to Cart

Global Pituitary Cancer Market Size Status and Forecast 2021 2027
Global Pituitary Cancer Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-16T5976
Fri Jul 16 00:00:00 UTC 2021

Add to Cart

Global Diabetic Assay Market Size Status and Forecast 2021 2027
Global Diabetic Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-37T1733
Mon Jul 12 00:00:00 UTC 2021

Add to Cart